EGCG, the main bioactive compound found in green tea, has been intensively studied for its demethylating properties by acting as a DNA methyltransferase (DNMT) inhibitor in several types of lung cancer, leukaemia, and breast cancer, as well as in some neurodegenerative disorders. This evidence concerns the gene DNMT1 and breast carcinoma.